A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: episodic (5), intermittent (36), sporadic (4)

Capecitabine-Carboplatin(AUC5)-Cetuximab

Description
Chemotherapy Protocol HEAD AND NECK CANCER CAPECITABINE-CARBOPLATIN (AUC5)-CETUXIMAB Regimen • Head and Neck Cancer – Capecitabine-Carboplatin-Cetuximab Indication • The treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Capecitabine-Carboplatin-Cetuximab.pdf

Capecitabine-Cetuximab-Oxaliplatin

Description
Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE-CETUXIMAB-OXALIPLATIN (21 day) This regimen may require funding Regimen • Colorectal Cancer – Capecitabine-Cetuximab-Oxaliplatin (21
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Cetuximab-Oxaliplatin.pdf

Dabrafenib Ver 1

Description
Chemotherapy Protocol SKIN CANCER DABRAFENIB Regimen Skin – Dabrafenib Indication Dabrafenib is recommended as an option for the first line treatment of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinDabrafenibVer1.pdf

Blinatumomab

Description
Chemotherapy Protocol Acute lymphoblastic leukaemia (ALL) Blinatumomab (3, 4 day) Regimen • ALL – Blinatumomab (3, 4 day schedule) Indication • Treatment of Phila
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/ALL/Blinatumomab.pdf

DRD Daratumumab-Lenalidomide-Dexamethasone

Description
Chemotherapy Protocol Myeloma DRD Daratumumab-Lenalidomide-Dexamethasone Regimen • Myeloma – DRD Daratumumab-Lenalidomide-Dexamethasone I
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DRD-Daratumumab-Lenalidomide-Dexamethasone.pdf

Selinexor Bortezomib Dexamethasone

Description
Chemotherapy Protocol Multiple Myeloma Selinexor with Bortezomib and Dexamethasone Regimen • SELINEXOR (PO) – BORTEZOMIB (SC) – DEXAMETHASONE (PO) Indication Selinexor plus bortezomib and
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Selinexor-Bortezomib-Dexamethasone-Ver1.pdf

Carfilzomib-Dexamethasone(20) Ver1

Description
Chemotherapy Protocol MYELOMA Carfilzomib-Dexamethasone (20) Regimen • Myeloma – Carfilzomib-Dexamethasone (20) Indication • Carfilzomib in combination with dexamethasone is an option for
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/carfilzomib-dexamethasone20-ver1.pdf

Binimetinib-Encorafenib

Description
Chemotherapy Protocol SKIN CANCER Binimetinib-Encorafenib Regimen • Skin – Binimetinib-Encorafenib Indication • Unresectable or metastatic BRAF V600 mutat
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Binimetinib-Encorafenib.pdf

Lenvatinib(60kg or greater)

Description
Chemotherapy Protocol HEPATOCELLULAR CANCER LENVATINIB (60kg or greater) Regimen • Hepatocellular – Lenvatinib Indication • Lenvatinib is indicated where either; - the patient has a
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Lenvatinib-60kg-or-greater-Ver1.pdf

Lenvatinib(59kg or less)

Description
Chemotherapy Protocol HEPATOCELLULAR CANCER LENVATINIB (59kg or less) Regimen • Hepatocellular – Lenvatinib Indication • Lenvatinib is indicated where either; - the patient has a
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Lenvatinib-59kg-or-less-.pdf
51 to 60 of 187
Previous … 4 5 6 7 8 … Next